Free Trial
ASX:ACL

Australian Clinical Labs (ACL) Stock Price, News & Analysis

Australian Clinical Labs logo

About Australian Clinical Labs Stock (ASX:ACL)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
$728.27 million
P/E Ratio
30.38
Dividend Yield
3.28%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Australian Clinical Labs Limited provides pathology services in Australia. The company offers range of services, which include routine pathology test, advanced molecular genetics testing, harmony NIPT and first trimester screening, genetic carrier screening, chemical pathology, histopathology, and cytopathology; hematology, allergy, and immunology; serology and microbiology; and infectious molecular testing, cardiac testing services, functional pathology, veterinary pathology, and commercial drug and alcohol testing services. It offers its service to private and public hospitals. Australian Clinical Labs Limited was incorporated in 2020 and is headquartered in Clayton, Australia.

Receive ACL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Australian Clinical Labs and its competitors with MarketBeat's FREE daily newsletter.

ACL Stock News Headlines

52 Money Mondays for $7 (This Weekend Only)
Right now, for a limited time… You can get up to 52 Money Monday trades for just $7! Thanks to Wall Street’s “Most Wanted” trader, who just put the finishing touches on his brand-new Money Monday algorithm.
See More Headlines

ACL Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Australian Clinical Labs investors own include Allied Gaming & Entertainment (AGAE), Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM), Academy Sports and Outdoors (ASO), Berkeley Energia (BKY), Global X Cloud Computing ETF (CLOU) and Coles Group (COL).

Company Calendar

Ex-Dividend for 4/15 Dividend
3/26/2025
Record date for 4/15 Dividend
4/15/2025
Dividend Payable
4/15/2025
Today
5/24/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
Current Symbol
ASX:ACL
CIK
N/A
Fax
N/A
Employees
5,115
Year Founded
N/A

Profitability

Trailing P/E Ratio
30.38
Forward P/E Ratio
N/A
P/E Growth
-0.36
Net Income
$23.93 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$696.37 million
Price / Cash Flow
N/A
Book Value
A$0.89 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$728.27 million
Optionable
Not Optionable
Beta
1.18
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report

This page (ASX:ACL) was last updated on 5/24/2025 by MarketBeat.com Staff
From Our Partners